Furthermore, we evaluated the effects of lovastatin on endothelial cell proliferation and survival as well as the effects of combining lovastatin with VEGFR-TKIs on MM tumor cell viability as a potential novel therapeutic approach. Here, KDR is linked to neoplasm.